Shreya Pal (Scientific Student Worker) for ViiV Healthcare working in a lab

OUR HIV MEDICINES

Our product portfolio consists of 16 prescription medicines, all for the treatment of human immunodeficiency virus (HIV). These medicines may not be available in all countries. Additionally, currently approved indications (uses) and presentations may differ between countries.

Please note that we are unable to provide detailed information about prescription medicines on this website in compliance with UK regulations.

You can find local information by clicking the button below and selecting your country of residence which will take you to your country specific website if available.

Select your Country


Healthcare Professionals

If you are a Healthcare Professional looking for information on ViiV Healthcare products, click the button below and select your country of residence.

Healthcare Professionals

Denotes that this medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. Please see the right hand tool bar for instructions on how to report a side effect.

Trademark
International non-proprietary
name
Vocabria
cabotegravir
Rukobia
fostemsavir
Cabenuva cabotegravir/rilpivirine
Dovato dolutegravir/lamivudine
Juluca dolutegravir/rilpivirine
Triumeq dolutegravir/ abacavir/ lamivudine
Tivicay dolutegravir
Selzentry/ Celsentri maraviroc
Epzicom/ Kivexa abacavir/ lamivudine
Ziagen abacavir
Trizivir abacavir/ lamivudine/ zidovudine
Combivir lamivudine/ zidovudine
Epivir lamivudine
Retrovir zidovudine
Lexiva/ Telzir fosamprenavir
Viracept nelfinavir

Report a side effect

Our Privacy Notice outlines how ViiV Healthcare handles the processing of personal information when dealing with your enquiry, side effect or complaint.

Side effects should be reported to the Regulatory Authorities. If you are located in the UK, reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ If you are located outside of the UK, please refer to your national reporting system.

Side effects should also be reported to ViiV Healthcare.

To report a side effect, please use the online reporting form below. This facility is provided by GSK, so you will be redirected to a GSK webpage.

Report a side effect

Date of preparation: November 2021

Visit your local site for Non Healthcare Professionals

Please select an option below to find further information about ViiV Healthcare medicines in your country

Visit your local site for Healthcare Professionals

Please select an option below to find further information about ViiV Healthcare medicines in your country